Results 11 to 20 of about 37,893 (278)

Immunotherapeutic potential of oncolytic vaccinia virus [PDF]

open access: yesImmunologic Research, 2014
The concept of oncolytic viral therapy was based on the hypothesis that engineering tumor-selectivity into the replication potential of viruses would permit direct destruction of tumor cells as a result of viral-mediated lysis, resulting in amplification
Thorne, SH
core   +7 more sources

Oncolytic Virus Immunotherapy [PDF]

open access: yesCancers, 2021
Oncolytic viruses (OVs) were originally developed as direct cytotoxic agents but have been increasingly recognised as a form of immunotherapy [...]
Marchini, Antonio   +2 more
openaire   +2 more sources

Oncolytic Virotherapy with Myxoma Virus [PDF]

open access: yesJournal of Clinical Medicine, 2020
Oncolytic viruses are one of the most promising novel therapeutics for malignant cancers. They selectively infect and kill cancer cells while sparing the normal counterparts, expose cancer- specific antigens and activate the host immune system against both viral and tumor determinants.
Masmudur M. Rahman, Grant McFadden
openaire   +2 more sources

Recent advances in oncolytic virus therapy for hepatocellular carcinoma

open access: yesFrontiers in Oncology, 2023
Hepatocellular carcinoma (HCC) is a highly refractory cancer and the fourth leading cause of cancer-related mortality worldwide. Despite the development of a detailed treatment strategy for HCC, the survival rate remains unsatisfactory.
Licheng Zhu   +14 more
doaj   +1 more source

Neutrophils in oncolytic virus immunotherapy. [PDF]

open access: yesFront Immunol
Oncolytic viruses have emerged as a highly promising modality for cancer treatment due to their ability to replicate specifically within tumors, carry therapeutic genes, and modulate the immunosuppressive tumor microenvironment through various mechanisms. Additionally, they show potential synergy with immune checkpoint inhibitors.
Zhou D, Zhang C, Sun J, Yuan M.
europepmc   +4 more sources

Suppression of CCDC6 sensitizes tumor to oncolytic virus M1

open access: yesNeoplasia: An International Journal for Oncology Research, 2021
Oncolytic virus is an effective therapeutic strategy for cancer treatment, which exploits natural or manipulated viruses to selectively target and kill cancer cells.
Ying Liu   +12 more
doaj   +1 more source

Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
Oncolytic virus therapy has advanced rapidly in recent years. Natural or transgenic viruses can target tumor cells and inhibit tumor growth and metastasis in various ways without interfering with normal cell and tissue function.
Qingbo Li   +9 more
doaj   +1 more source

Measles Virus as an Oncolytic Immunotherapy [PDF]

open access: yesCancers, 2021
Measles virus (MeV) preferentially replicates in malignant cells, leading to tumor lysis and priming of antitumor immunity. Live attenuated MeV vaccine strains are therefore under investigation as cancer therapeutics. The versatile MeV reverse genetics systems allows for engineering of advanced targeted, armed, and shielded oncolytic viral vectors ...
Christine E. Engeland, Guy Ungerechts
openaire   +2 more sources

Atomic Resolution Structure of the Oncolytic Parvovirus LuIII by Electron Microscopy and 3D Image Reconstruction. [PDF]

open access: yes, 2017
LuIII, a protoparvovirus pathogenic to rodents, replicates in human mitotic cells, making it applicable for use to kill cancer cells. This virus group includes H-1 parvovirus (H-1PV) and minute virus of mice (MVM).
Agbandje-McKenna, Mavis   +13 more
core   +9 more sources

Oncolytic Virotherapy for Cancer: Clinical Experience

open access: yesBiomedicines, 2021
Oncolytic viruses are a new class of therapeutics which are largely in the experimental stage, with just one virus approved by the FDA thus far. While the concept of oncolytic virotherapy is not new, advancements in the fields of molecular biology and ...
Shyambabu Chaurasiya   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy